John D. Mills
Fondateur chez Tissupath Pty Ltd.
Profil
John D.
Mills is the founder of Tissupath Pty Ltd.
(founded in 2004) and holds the title of Director-Research & Development.
He is currently the Executive Chairman at Cavidi AB and a Non-Executive Director at the Prostate Cancer Foundation of Australia.
In the past, he served as the Non-Executive Chairman at CSL Innovation Pty Ltd.
from 1995 to 2003, Independent Non-Executive Director at Avecho Biotechnology Ltd.
from 2004 to 2010, Managing Director at ResApp Health Ltd.
in 2007, and Managing Director at The Macfarlane Burnet Institute For Medical Research & Public.
He also held the position of Director at Adherium (NZ) Ltd.
from 2015 to 2019 and Independent Non-Executive Director at Adherium Ltd.
from 2015 to 2019.
Additionally, he was an Investment Committee Member at GBS Venture Partners Pty Ltd.
Dr. Mills completed his undergraduate studies at The University of Chicago and Harvard Medical School.
Postes actifs de John D. Mills
| Sociétés | Poste | Début |
|---|---|---|
Cavidi AB
 Cavidi AB Pharmaceuticals: MajorHealth Technology Cavidi AB develops and manufactures IVD tests for detection and monitoring of viral diseases. Its ExaVir product series utilizes the HIV reverse transcriptase enzyme to measure viral load and drug susceptibility. The company develops front-line assays for various polymerase enzymes of interest to pharmaceutical, medical, and veterinary research. It offers hospitals, private laboratories, pharmaceutical industries, and research institutions worldwide. Cavidi was founded in 1984 and is headquartered in Uppsala, Sweden. | Président | 26/11/2010 |
Tissupath Pty Ltd.
 Tissupath Pty Ltd. Medical/Nursing ServicesHealth Services Tissupath Pty Ltd. operates as a specialist pathology practice firm. The firm's services include reports, turnaround times for reports, reports tailored to individual clinicians, double reporting of all biopsies and volumetric mapping for selected malignancies. The company was founded by John Mills in 2004 and is headquartered in Mount Waverley, Australia. | Fondateur | 01/01/2004 |
| Prostate Cancer Foundation of Australia | Directeur/Membre du Conseil | 10/12/2010 |
Anciens postes connus de John D. Mills
| Sociétés | Poste | Fin |
|---|---|---|
| ADHERIUM LIMITED | Directeur/Membre du Conseil | 21/10/2019 |
Adherium (NZ) Ltd.
 Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Adherium (NZ) Ltd. develops digital health technologies that address sub-optimal medication use in chronic disease. It offers Smartinhaler platform. The firm delivers original equipment manufacturer (OEM) products, software and services via development, regulatory, licensing, and supply and support agreements. The company was founded by Sutherland Garth Campbell in 2001 and is headquartered in Auckland, New Zealand. | Directeur/Membre du Conseil | 18/10/2019 |
| AVECHO BIOTECHNOLOGY LIMITED | Directeur/Membre du Conseil | 24/08/2010 |
| RESP HEAL | Directeur Général | 17/12/2007 |
| ZENYTH THERAPEUTICS LIMITED | Président | 01/01/2003 |
Formation de John D. Mills
| The University of Chicago | Undergraduate Degree |
| Harvard Medical School | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AVECHO BIOTECHNOLOGY LIMITED | Health Technology |
| ADHERIUM LIMITED | Health Technology |
| Entreprise privées | 8 |
|---|---|
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
ResApp Health Ltd.
 ResApp Health Ltd. Packaged SoftwareTechnology Services ResApp Health Ltd. engages in the research and commercial development of ResApp technology for the purpose of providing health care solutions for respiratory disease. The technology is based on a machine learning algorithm that uses sound alone without the need for additional hardware to diagnose and measure the severity of a respiratory condition. ResApp’s core technology uses sound to diagnose respiratory diseases including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease and asthma. The company was founded on September 13, 2000 by John Majewski and is headquartered in Brisbane, Australia. | Technology Services |
GBS Venture Partners Pty Ltd.
 GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partners Pty Ltd (GBS Venture Partners) is a venture capital firm founded in 1996 by Helen Brigitte Smith and Geoff E.D Brooke. The firm is headquartered in Melbourne. | Finance |
The Macfarlane Burnet Institute For Medical Research & Public
 The Macfarlane Burnet Institute For Medical Research & Public Miscellaneous Commercial ServicesCommercial Services The Macfarlane Burnet Institute For Medical Research & Public Health Ltd. provides medical research and public health services. Its programs include maternal health, disease elimination, behaviors and health risks, health security, and healthy ageing. The organization also focuses on women's and children's health; alcohol, other drugs and harm reduction; sexual and reproductive health; and young people's health. The organization was founded in 1986 headquartered in Melbourne, Australia. | Commercial Services |
Cavidi AB
Cavidi AB Pharmaceuticals: MajorHealth Technology Cavidi AB develops and manufactures IVD tests for detection and monitoring of viral diseases. Its ExaVir product series utilizes the HIV reverse transcriptase enzyme to measure viral load and drug susceptibility. The company develops front-line assays for various polymerase enzymes of interest to pharmaceutical, medical, and veterinary research. It offers hospitals, private laboratories, pharmaceutical industries, and research institutions worldwide. Cavidi was founded in 1984 and is headquartered in Uppsala, Sweden. | Health Technology |
Adherium (NZ) Ltd.
Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Adherium (NZ) Ltd. develops digital health technologies that address sub-optimal medication use in chronic disease. It offers Smartinhaler platform. The firm delivers original equipment manufacturer (OEM) products, software and services via development, regulatory, licensing, and supply and support agreements. The company was founded by Sutherland Garth Campbell in 2001 and is headquartered in Auckland, New Zealand. | Technology Services |
| Prostate Cancer Foundation of Australia | |
Tissupath Pty Ltd.
Tissupath Pty Ltd. Medical/Nursing ServicesHealth Services Tissupath Pty Ltd. operates as a specialist pathology practice firm. The firm's services include reports, turnaround times for reports, reports tailored to individual clinicians, double reporting of all biopsies and volumetric mapping for selected malignancies. The company was founded by John Mills in 2004 and is headquartered in Mount Waverley, Australia. | Health Services |
